Search hospitals > Texas > Houston
St. Luke's Episcopal Hospital
Claim this profileHouston, Texas 77030
Global Leader in Coronary Artery Disease
Conducts research for Hepatitis
Conducts research for Hepatitis C
Conducts research for Cancer
Conducts research for Atrial Fibrillation
147 reported clinical trials
22 medical researchers
Summary
St. Luke's Episcopal Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Coronary Artery Disease, Hepatitis, Hepatitis C, Cancer, Atrial Fibrillation and other specialties. St. Luke's Episcopal Hospital is involved with conducting 147 clinical trials across 236 conditions. There are 22 research doctors associated with this hospital, such as Mohamed O. Othman, MD, Joseph Coselli, MD, Guilherme Silva, MD, and Tannaz Armaghany.Top PIs
Mohamed O. Othman, MDBaylor College of Medicine3 years of reported clinical research
Studies Gastrointestinal Tumors
Studies Digestive System Tumors
17 reported clinical trials
27 drugs studied
Joseph Coselli, MDBaylor College of Medicine5 years of reported clinical research
Studies Aortic Aneurysm
Studies Aneurysm
9 reported clinical trials
12 drugs studied
Guilherme Silva, MDBaylor College of Medicine St. Luke's Medical Center5 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Stroke
7 reported clinical trials
9 drugs studied
Tannaz ArmaghanyBaylor College of Medicine4 years of reported clinical research
Studies Hepatocellular Carcinoma
Studies Adenocarcinoma
6 reported clinical trials
13 drugs studied
Clinical Trials running at St. Luke's Episcopal Hospital
Pulmonary Arterial Hypertension
Pancreatic Cancer
Breast Cancer
Adenocarcinoma
High Blood Pressure
Pulmonary Hypertension
Leukemia
Chronic Myeloid Leukemia
Head and Neck Cancers
Pancreatic Adenocarcinoma
Sotatercept
for Pulmonary Arterial Hypertension
This trial is testing sotatercept, a medication for high blood pressure in the lungs, in adults with PAH who have completed earlier studies. It aims to see if the medication is safe and effective over a long period. Sotatercept helps lung blood vessels function better, reducing lung pressure. Sotatercept has shown promising results in earlier studies for reducing lung pressure and improving exercise tolerance in patients with pulmonary arterial hypertension (PAH).
Recruiting2 awards Phase 39 criteria
Seralutinib
for Pulmonary Arterial Hypertension
This trial is testing a medication called seralutinib to see if it can help people with a specific type of lung disease (PAH) improve their ability to exercise. The medication works by blocking signals that cause the blood vessels in the lungs to tighten and narrow. Seralutinib is delivered via inhalation and is being developed for patients with pulmonary arterial hypertension. The goal is to see if this can reduce lung pressure and delay worsening of the disease.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at St. Luke's Episcopal Hospital?
St. Luke's Episcopal Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Coronary Artery Disease, Hepatitis, Hepatitis C, Cancer, Atrial Fibrillation and other specialties. St. Luke's Episcopal Hospital is involved with conducting 147 clinical trials across 236 conditions. There are 22 research doctors associated with this hospital, such as Mohamed O. Othman, MD, Joseph Coselli, MD, Guilherme Silva, MD, and Tannaz Armaghany.